Dr Amol Soin elected president of the Society of Interventional Pain Management Surgery Centers and the ASIPP Foundation

DAYTON, Ohio, March 14, 2018 /PRNewswire/ -- Dr Amol Soin, CEO of Soin Neuroscience, was elected to serve as president of the Society of Interventional Pain Management Surgery Centers (SIPMS) as well as the ASIPP Foundation for 2018. ASIPP, also known as the American Society of Interventional Pain Physicians, is a leading medical advocacy society of pain management physicians. The Society of Interventional Pain Management Surgery Centers is a national society, born from ASIPP,that advocates for surgery centers. SIPMS and ASIPP will hold a joint annual meeting from March 15^th ? 17^th in Orlando, Florida. The ASIPP Foundation is a separate affiliated entity than the main ASIPP society, and the foundation is an organization that advocates for patients and physicians who suffer from pain through charitable donations and events. The ASIPP foundation also participates in other areas of community need, for example, last year the foundation participated in a Hurricane Harvey relief fund.

About Soin Neuroscience:
Soin Neuroscience (SNI) is a pharmaceutical startup company based in Dayton, OH that specializes in treating pain and other neurological conditions. Its lead compound, TV1001SR, is entering late stage trials to treat systemic sclerosis and diabetic peripheral neuropathy. SNI also has multiple other compounds in development including a way to restore functional motor and cognitive function after ischemic stroke, a method to treat intensive care unit myopathy, and is working on an option to treat Huntington's disease. The company was founded by Dr. Amol Soin who is also an inventor on most of the core technologies that are being developed. He can be reached at [email protected].

SOURCE Soin Neuroscience